DK1259512T3 - Pteridinforbindelser til behandling af psoreasis - Google Patents

Pteridinforbindelser til behandling af psoreasis

Info

Publication number: DK1259512T3
Authority: DK; Denmark
Prior art keywords: psoreasis; treatment; pteridine compounds; pteridine; compounds
Prior art date: 2000-02-23

Application number

DK01906493T

Other languages

English (en)

Inventor

Stewart Gardiner

Roger Bonnert

Fraser Hunt

Iain Walters

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-23

Filing date

2001-02-20

Publication date

2003-12-29

2001-02-20 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-12-29 Application granted granted Critical

2003-12-29 Publication of DK1259512T3 publication Critical patent/DK1259512T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Pulmonology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Addiction (AREA)
Orthopedic Medicine & Surgery (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

DK01906493T 2000-02-23 2001-02-20 Pteridinforbindelser til behandling af psoreasis DK1259512T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0004128A GB2359551A (en)	2000-02-23	2000-02-23	Pharmaceutically active pyrimidine derivatives
PCT/SE2001/000374 WO2001062758A1 (en)	2000-02-23	2001-02-20	Pteridine compounds for the treatment of psoriasis

Publications (1)

Publication Number	Publication Date
DK1259512T3 true DK1259512T3 (da)	2003-12-29

Family

ID=9886153

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01906493T DK1259512T3 (da)	2000-02-23	2001-02-20	Pteridinforbindelser til behandling af psoreasis

Country Status (32)

Country	Link
US (2)	US6875868B2 (da)
EP (1)	EP1259512B1 (da)
JP (1)	JP2003524012A (da)
KR (1)	KR100795758B1 (da)
CN (1)	CN1190437C (da)
AR (1)	AR029805A1 (da)
AT (1)	ATE250605T1 (da)
AU (1)	AU782509B2 (da)
BG (1)	BG107002A (da)
BR (1)	BR0108600A (da)
CA (1)	CA2400217C (da)
CO (1)	CO5290258A1 (da)
CZ (1)	CZ20022839A3 (da)
DE (1)	DE60100851T2 (da)
DK (1)	DK1259512T3 (da)
EE (1)	EE200200461A (da)
ES (1)	ES2206402T3 (da)
GB (1)	GB2359551A (da)
HU (1)	HUP0204399A3 (da)
IL (2)	IL151132A0 (da)
IS (1)	IS6491A (da)
MX (1)	MXPA02008233A (da)
NO (1)	NO329898B1 (da)
NZ (1)	NZ520355A (da)
PL (1)	PL358004A1 (da)
PT (1)	PT1259512E (da)
RU (1)	RU2002125451A (da)
SK (1)	SK12152002A3 (da)
TR (1)	TR200302214T4 (da)
UA (1)	UA72590C2 (da)
WO (1)	WO2001062758A1 (da)
ZA (1)	ZA200206590B (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9903544D0 (sv) *	1999-10-01	1999-10-01	Astra Pharma Prod	Novel compounds
GB2359078A (en)	2000-02-11	2001-08-15	Astrazeneca Uk Ltd	Pharmaceutically active pyrimidine derivatives
GB2359081A (en)	2000-02-11	2001-08-15	Astrazeneca Uk Ltd	Pharmaceutically active thiazolopyrimidines
GB2359551A (en) *	2000-02-23	2001-08-29	Astrazeneca Uk Ltd	Pharmaceutically active pyrimidine derivatives
SE0003828D0 (sv)	2000-10-20	2000-10-20	Astrazeneca Ab	Novel compounds
WO2002083143A1 (en)	2000-12-11	2002-10-24	Tularik Inc.	Cxcr3 antagonists
SE0101322D0 (sv) *	2001-04-12	2001-04-12	Astrazeneca Ab	Novel compounds
US6794379B2 (en)	2001-06-06	2004-09-21	Tularik Inc.	CXCR3 antagonists
SE0102716D0 (sv) *	2001-08-14	2001-08-14	Astrazeneca Ab	Novel compounds
GB0221829D0 (en) *	2002-09-20	2002-10-30	Astrazeneca Ab	Novel compound
GB0221828D0 (en) *	2002-09-20	2002-10-30	Astrazeneca Ab	Novel compound
US7067658B2 (en)	2002-09-30	2006-06-27	Bristol-Myers Squibb Company	Pyridino and pyrimidino pyrazinones
US6861422B2 (en)	2003-02-26	2005-03-01	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
GB0328243D0 (en) *	2003-12-05	2004-01-07	Astrazeneca Ab	Methods
US7375102B2 (en)	2004-06-28	2008-05-20	Amgen Sf, Llc	Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use
US7939538B2 (en)	2004-06-28	2011-05-10	Amgen Inc.	Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
US7271271B2 (en)	2004-06-28	2007-09-18	Amgen Sf, Llc	Imidazolo-related compounds, compositions and methods for their use
DE102004033670A1 (de) *	2004-07-09	2006-02-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US7759485B2 (en)	2004-08-14	2010-07-20	Boehringer Ingelheim International Gmbh	Process for the manufacture of dihydropteridinones
US20060074088A1 (en) *	2004-08-14	2006-04-06	Boehringer Ingelheim International Gmbh	Dihydropteridinones for the treatment of cancer diseases
US7728134B2 (en)	2004-08-14	2010-06-01	Boehringer Ingelheim International Gmbh	Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US20060035903A1 (en)	2004-08-14	2006-02-16	Boehringer Ingelheim International Gmbh	Storage stable perfusion solution for dihydropteridinones
US20060058311A1 (en)	2004-08-14	2006-03-16	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation
DE102004058337A1 (de)	2004-12-02	2006-06-14	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
AU2005316668B2 (en) *	2004-12-13	2012-09-06	Millennium Pharmaceuticals, Inc.	Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors
UA90707C2 (en)	2005-04-06	2010-05-25	Астразенека Аб	Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives
AR053347A1 (es)	2005-04-06	2007-05-02	Astrazeneca Ab	Derivados de [1,3]tiazolo[4,5-d]pirimidin-2(3h)-ona 5,7-sustituidos
US7439358B2 (en) *	2006-02-08	2008-10-21	Boehringer Ingelheim International Gmbh	Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
AU2007300749B2 (en) *	2006-09-29	2011-08-25	Astrazeneca Ab	Novel 5,7-disubstituted [1, 3] thiazolo [4, 5] pyrimidin-2 (3H)-amine derivatives and their use in therapy
TW200820973A (en) *	2006-09-29	2008-05-16	Astrazeneca Ab	Novel compounds 480
WO2009019205A1 (en)	2007-08-03	2009-02-12	Boehringer Ingelheim International Gmbh	Crystalline form of a dihydropteridione derivative
BRPI0915908A2 (pt) *	2008-07-16	2018-07-10	Astrazeneca Ab	derivado de pirimidil sulfonamida e seu uso para o tratamento de doenças mediadas por quimiocina
US8546566B2 (en)	2010-10-12	2013-10-01	Boehringer Ingelheim International Gmbh	Process for manufacturing dihydropteridinones and intermediates thereof
US9358233B2 (en)	2010-11-29	2016-06-07	Boehringer Ingelheim International Gmbh	Method for treating acute myeloid leukemia
US9370535B2 (en)	2011-05-17	2016-06-21	Boehringer Ingelheim International Gmbh	Method for treatment of advanced solid tumors
CA2837227C (en)	2011-06-01	2022-05-10	Janus Biotherapeutics, Inc.	Novel immune system modulators
JP2016528185A (ja)	2013-06-18	2016-09-15	ニューヨーク・ユニバーシティ	黄色ブドウ球菌ロイコシジンの細胞毒性に関与する細胞因子：新規治療標的
WO2015011236A1 (en)	2013-07-26	2015-01-29	Boehringer Ingelheim International Gmbh	Treatment of myelodysplastic syndrome
US9867831B2 (en)	2014-10-01	2018-01-16	Boehringer Ingelheim International Gmbh	Combination treatment of acute myeloid leukemia and myelodysplastic syndrome

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2924472A (en) *	1957-06-27	1960-02-09	Gen Motors Corp	Pipe joint seal
GB1009477A (en)	1962-02-13	1965-11-10	Smith Kline French Lab	Novel process for preparing heterocyclic compounds
US3318900A (en) *	1964-05-06	1967-05-09	Janssen Pharmaceutica Nv	Derivatives of benzimidazolinyl piperidine
BE668603A (da) *	1964-08-20
US3859287A (en) *	1971-05-05	1975-01-07	Walter Wesley Parish	Thiopteridines and process for producing same
DE2331223C2 (de)	1972-06-19	1984-11-22	Kohjin Co., Ltd., Tokio / Tokyo	S-substituierte-2-Thioadenosine, deren 5'-Monophosphate, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten
US4120521A (en) *	1975-08-28	1978-10-17	Rieber & Son Plastic-Industri A/S	Combined mould element and sealing ring
EG12406A (en) *	1976-08-12	1979-03-31	Janssen Pharmaceutica Nv	Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
GB1600293A (en) *	1977-02-04	1981-10-14	British Oceanics Ltd	Sealing arrangements
US4188040A (en) *	1977-04-06	1980-02-12	Firma WOCO Franz-Josef Wolf & Co.	Sealing ring
DE2726959A1 (de) *	1977-06-15	1979-01-18	Arlt Christian	Dichteinsatz zum dichten verbinden von zwei rohren
FR2421899A1 (fr) *	1978-01-16	1979-11-02	Roussel Uclaf	Nouveaux derives du tetrahydropyridinyl-indole et leurs sels, le procede de preparation et l'application a titre de medicaments de ces nouveaux produits
US4410528A (en) *	1980-05-16	1983-10-18	Kyowa Hakko Kogyo Co., Ltd.	Hypotensive piperidine derivatives
DE3219522A1 (de) *	1981-10-28	1983-12-01	Denso-Chemie Wedekind Kg, 5090 Leverkusen	Steckmuffendichtung fuer rohre
FR2547888B1 (fr) *	1983-06-22	1985-12-13	Sabla Sa	Bague d'etancheite a implants pour tuyaux a emboitement
HU195822B (en) *	1985-12-30	1988-07-28	Gyogyszerkutato Intezet	Process for producing new pyrimido/5,4-b//1,h/oxazine derivatives
CA1338012C (en) *	1987-04-27	1996-01-30	John Michael Mccall	Pharmaceutically active amines
SE8800348L (sv) *	1988-02-03	1989-08-04	Forsheda Ab	Taetningsring och verktyg foer framstaellning daerav
FR2659656B1 (fr) *	1990-03-15	1994-09-09	Sanofi Sa	Derives de pyrimidinedione-2,4 et medicaments les contenant.
DE4119767A1 (de)	1991-06-15	1992-12-17	Dresden Arzneimittel	Verfahren zur herstellung von (pyrimid-2-yl-thio- bzw. seleno)-essigsaeurederivaten
JP3100469B2 (ja) *	1991-07-03	2000-10-16	中外製薬株式会社	乾癬治療剤
US5169161A (en) *	1991-09-19	1992-12-08	Hail Mary Rubber Co., Inc.	Symmetrical gasket for pipe joints
DE4134089C2 (de) *	1991-10-15	1994-10-13	Dueker Eisenwerk	Schubgesicherte Muffenverbindung
JPH05188994A (ja)	1992-01-07	1993-07-30	Sony Corp	騒音抑圧装置
DE4229609C2 (de) *	1992-09-04	2003-05-08	Forsheda Stefa Gmbh	Abdichtung zwischen zwei ineinandersteckbaren Teilen
US5521197A (en)	1994-12-01	1996-05-28	Eli Lilly And Company	3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
DK0778277T3 (da)	1995-12-08	2003-10-27	Pfizer	Substituerede heterocycliske derivater som CRF antagonister
GB9624482D0 (en)	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
SE515033C2 (sv) *	1995-12-27	2001-06-05	Forsheda Ab	Tätningsanordning
HUP9901155A3 (en)	1996-02-13	2003-04-28	Astrazeneca Ab	Quinazoline derivatives as vegf inhibitors
ATE211134T1 (de)	1996-03-05	2002-01-15		4-anilinochinazolin derivate
EP0898568B1 (en)	1996-04-19	2006-10-04	Neurosearch A/S	1-(4-piperidyl)-benzimidazoles having neurotrophic activity
DE69736711T2 (de)	1996-08-28	2007-09-20	Pfizer Inc.	Substituierte 6,5-heterobicyclische-derivate
GB9718972D0 (en)	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
WO1998025617A1 (en)	1996-12-13	1998-06-18	Merck & Co., Inc.	Substituted aryl piperazines as modulators of chemokine receptor activity
GB9714249D0 (en)	1997-07-08	1997-09-10	Angiogene Pharm Ltd	Vascular damaging agents
JP2002510327A (ja)	1997-07-25	2002-04-02	メルクエンドカンパニーインコーポレーテッド	環状アミンケモカイン受容体活性調節剤
AR013669A1 (es)	1997-10-07	2001-01-10	Smithkline Beecham Corp	Compuestos y metodos
CA2311742C (en) *	1997-11-28	2009-06-16	Sumitomo Pharmaceuticals Co., Ltd.	6-amino-9-benzyl-8-hydroxypurine derivatives
DE69901934T2 (de)	1998-01-19	2002-11-07	Pfizer Inc., New York	4-(2-keto-1-benzimidazolinyl)piperidin derivate als orl1-rezeptor agoniste
US6407121B1 (en) *	1998-03-19	2002-06-18	Nihon Nohyaku Co., Ltd.	Arylpiperidine derivatives and use thereof
JP2002510695A (ja)	1998-04-03	2002-04-09	デュポンファーマシューティカルズカンパニー	副腎皮質刺激ホルモン放出因子（ＣＲＦ）拮抗剤としてのチアゾロ［４，５−ｄ］ピリミジンおよびピリジン
MA26659A1 (fr) *	1998-08-06	2004-12-20	Pfizer	Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
SE9802729D0 (sv)	1998-08-13	1998-08-13	Astra Pharma Prod	Novel Compounds
US5988695A (en) *	1998-08-26	1999-11-23	S&B Technical Products, Inc.	Pipe gasket with embedded ring
PE20001420A1 (es)	1998-12-23	2000-12-18	Pfizer	Moduladores de ccr5
ES2229803T3 (es) *	1998-12-28	2005-04-16	4 Aza Bioscience Nv	Efectos inmunosupresivos de derivados de pteridina.
GB9900334D0 (en)	1999-01-07	1999-02-24	Angiogene Pharm Ltd	Tricylic vascular damaging agents
GB9900752D0 (en)	1999-01-15	1999-03-03	Angiogene Pharm Ltd	Benzimidazole vascular damaging agents
JP2002536320A (ja)	1999-02-02	2002-10-29	カー・イュー・ルーベン・リサーチ・アンド・ディベロップメント	プテリジン誘導体の免疫抑制作用
US6248755B1 (en)	1999-04-06	2001-06-19	Merck & Co., Inc.	Pyrrolidine modulators of chemokine receptor activity
US6142484A (en) *	1999-04-15	2000-11-07	Vassallo Research & Development Corporation	Composite multi-pressure gasket
US6432981B1 (en) *	1999-06-11	2002-08-13	Merck & Co., Inc.	Cyclopentyl modulators of chemokine receptor activity
US6340681B1 (en)	1999-07-16	2002-01-22	Pfizer Inc	2-benzimidazolylamine compounds as ORL-1-receptor agonists
EA005287B1 (ru) *	1999-09-15	2004-12-30	Уорнер-Ламберт Компани	Птеридиноны в качестве ингибиторов киназ
SE9903544D0 (sv) *	1999-10-01	1999-10-01	Astra Pharma Prod	Novel compounds
PE20010628A1 (es)	1999-10-01	2001-06-18	Takeda Chemical Industries Ltd	Compuestos de amina ciclica, su produccion y su uso
EP1122257B1 (en)	2000-01-05	2005-10-12	Pfizer Inc.	Benzimidazole compounds as ORL1-receptor agonists
GB2359079A (en)	2000-02-11	2001-08-15	Astrazeneca Uk Ltd	Pharmaceutically active pyrimidine derivatives
WO2001058906A1 (en)	2000-02-11	2001-08-16	Astrazeneca Ab	Pyrimidine compounds and their use as modulators of chemokine receptor activity
GB2359081A (en) *	2000-02-11	2001-08-15	Astrazeneca Uk Ltd	Pharmaceutically active thiazolopyrimidines
GB2359078A (en) *	2000-02-11	2001-08-15	Astrazeneca Uk Ltd	Pharmaceutically active pyrimidine derivatives
GB2359551A (en) *	2000-02-23	2001-08-29	Astrazeneca Uk Ltd	Pharmaceutically active pyrimidine derivatives
GB0005642D0 (en) *	2000-03-10	2000-05-03	Astrazeneca Uk Ltd	Chemical compounds
AU2001242744B2 (en) *	2000-03-24	2005-07-21	Meiji Seika Kaisha Ltd	Diphenylalkylamine derivatives useful as opioid delta receptor ligands
CN1431999A (zh)	2000-05-31	2003-07-23	阿斯特拉曾尼卡有限公司	具有血管损伤活性的吲哚衍生物
KR20030014425A (ko)	2000-07-07	2003-02-17	앤지오젠 파마슈티칼스 리미티드	혈관 손상제인 콜치놀 유도체
SK52003A3 (en)	2000-07-07	2003-07-01	Angiogene Pharm Ltd	Colchinol derivatives as angiogenesis inhibitors, method for their preparation and pharmaceutical composition comprising the same
SE0003828D0 (sv) *	2000-10-20	2000-10-20	Astrazeneca Ab	Novel compounds
SE0004110L (sv) *	2000-11-10	2002-05-11	Forsheda Ab	Tätningsring
SE0101322D0 (sv) *	2001-04-12	2001-04-12	Astrazeneca Ab	Novel compounds
SE0102716D0 (sv)	2001-08-14	2001-08-14	Astrazeneca Ab	Novel compounds
GB0221828D0 (en)	2002-09-20	2002-10-30	Astrazeneca Ab	Novel compound
GB0221829D0 (en)	2002-09-20	2002-10-30	Astrazeneca Ab	Novel compound
WO2005033115A1 (en)	2003-10-07	2005-04-14	Astrazeneca Ab	New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1
GB0328243D0 (en) *	2003-12-05	2004-01-07	Astrazeneca Ab	Methods
WO2005082865A1 (ja)	2004-02-27	2005-09-09	Astellas Pharma Inc.	縮合二環性ピリミジン誘導体
US20090239882A1 (en)	2004-12-17	2009-09-24	Astrazeneca Ab	Thiazolopyramidine Compounds for the Modulation of Chemokine Receptor Activity

2000
- 2000-02-23 GB GB0004128A patent/GB2359551A/en not_active Withdrawn
2001
- 2001-02-20 NZ NZ520355A patent/NZ520355A/en not_active IP Right Cessation
- 2001-02-20 WO PCT/SE2001/000374 patent/WO2001062758A1/en not_active Application Discontinuation
- 2001-02-20 CZ CZ20022839A patent/CZ20022839A3/cs unknown
- 2001-02-20 SK SK1215-2002A patent/SK12152002A3/sk unknown
- 2001-02-20 UA UA2002097583A patent/UA72590C2/uk unknown
- 2001-02-20 AT AT01906493T patent/ATE250605T1/de active
- 2001-02-20 RU RU2002125451/04A patent/RU2002125451A/ru not_active Application Discontinuation
- 2001-02-20 EE EEP200200461A patent/EE200200461A/xx unknown
- 2001-02-20 EP EP01906493A patent/EP1259512B1/en not_active Expired - Lifetime
- 2001-02-20 AU AU34316/01A patent/AU782509B2/en not_active Ceased
- 2001-02-20 IL IL15113201A patent/IL151132A0/xx unknown
- 2001-02-20 KR KR1020027011047A patent/KR100795758B1/ko not_active Expired - Fee Related
- 2001-02-20 ES ES01906493T patent/ES2206402T3/es not_active Expired - Lifetime
- 2001-02-20 HU HU0204399A patent/HUP0204399A3/hu unknown
- 2001-02-20 DK DK01906493T patent/DK1259512T3/da active
- 2001-02-20 TR TR2003/02214T patent/TR200302214T4/xx unknown
- 2001-02-20 MX MXPA02008233A patent/MXPA02008233A/es active IP Right Grant
- 2001-02-20 PT PT01906493T patent/PT1259512E/pt unknown
- 2001-02-20 US US10/204,814 patent/US6875868B2/en not_active Expired - Fee Related
- 2001-02-20 CN CNB018054676A patent/CN1190437C/zh not_active Expired - Fee Related
- 2001-02-20 BR BR0108600-6A patent/BR0108600A/pt not_active Application Discontinuation
- 2001-02-20 JP JP2001562540A patent/JP2003524012A/ja active Pending
- 2001-02-20 DE DE60100851T patent/DE60100851T2/de not_active Expired - Lifetime
- 2001-02-20 CA CA002400217A patent/CA2400217C/en not_active Expired - Fee Related
- 2001-02-20 PL PL01358004A patent/PL358004A1/xx not_active Application Discontinuation
- 2001-02-21 CO CO01013781A patent/CO5290258A1/es not_active Application Discontinuation
- 2001-02-21 AR ARP010100773A patent/AR029805A1/es not_active Application Discontinuation
2002
- 2002-08-07 IS IS6491A patent/IS6491A/is unknown
- 2002-08-07 IL IL151132A patent/IL151132A/en not_active IP Right Cessation
- 2002-08-14 BG BG107002A patent/BG107002A/bg unknown
- 2002-08-16 ZA ZA200206590A patent/ZA200206590B/en unknown
- 2002-08-22 NO NO20024005A patent/NO329898B1/no not_active IP Right Cessation
2004
- 2004-07-15 US US10/891,833 patent/US7579342B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HUP0204399A2 (en)	2003-05-28
HUP0204399A3 (en)	2004-11-29
IL151132A0 (en)	2003-04-10
JP2003524012A (ja)	2003-08-12
TR200302214T4 (tr)	2004-01-21
NO20024005D0 (no)	2002-08-22
ZA200206590B (en)	2003-11-17
DE60100851D1 (de)	2003-10-30
ATE250605T1 (de)	2003-10-15
EE200200461A (et)	2003-12-15
CZ20022839A3 (cs)	2002-11-13
NO20024005L (no)	2002-10-22
CO5290258A1 (es)	2003-06-27
US6875868B2 (en)	2005-04-05
US7579342B2 (en)	2009-08-25
PT1259512E (pt)	2004-02-27
KR100795758B1 (ko)	2008-01-21
CN1190437C (zh)	2005-02-23
IL151132A (en)	2010-11-30
NZ520355A (en)	2005-01-28
RU2002125451A (ru)	2004-01-10
PL358004A1 (en)	2004-08-09
US20030055250A1 (en)	2003-03-20
AU782509B2 (en)	2005-08-04
HK1050899A1 (en)	2003-07-11
GB0004128D0 (en)	2000-04-12
SK12152002A3 (sk)	2003-03-04
US20050171345A1 (en)	2005-08-04
EP1259512B1 (en)	2003-09-24
WO2001062758A1 (en)	2001-08-30
AR029805A1 (es)	2003-07-16
CA2400217A1 (en)	2001-08-30
BG107002A (bg)	2003-04-30
BR0108600A (pt)	2002-11-12
MXPA02008233A (es)	2004-04-05
AU3431601A (en)	2001-09-03
CA2400217C (en)	2009-02-17
NO329898B1 (no)	2011-01-24
GB2359551A (en)	2001-08-29
IS6491A (is)	2002-08-07
ES2206402T3 (es)	2004-05-16
UA72590C2 (uk)	2005-03-15
CN1404482A (zh)	2003-03-19
KR20030005207A (ko)	2003-01-17
DE60100851T2 (de)	2004-07-15
EP1259512A1 (en)	2002-11-27

Publication	Publication Date	Title
DK1259512T3 (da)	2003-12-29	Pteridinforbindelser til behandling af psoreasis
DK1292594T3 (da)	2004-12-06	Quinazolinderivater til behandling af tumorer
DK1147083T3 (da)	2004-08-16	Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1343773T3 (da)	2007-02-05	Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1296935T3 (da)	2009-06-22	Fremgangsmåde til fremstilling af substituerede octanoylamider
DK2412368T3 (da)	2013-11-04	Sammensætning til behandling af ar
DK1144395T3 (da)	2005-08-15	2-amino-benzoxazinon-derivater til behandling af fedme
DK1277722T3 (da)	2005-04-25	Fremgangsmåde til fremstilling af methanol
DK1063990T3 (da)	2007-05-21	Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1803718T3 (da)	2008-10-27	4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK1448205T3 (da)	2011-12-12	Kombinationer til behandling af immunoinflammatoriske sygdomme
DK1165576T3 (da)	2006-03-27	Fremgangsmåde til fremstilling af amin-platin-komplekser
DK1309545T3 (da)	2007-10-29	Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1499730T3 (da)	2014-01-13	Immunokonjugater til behandling af tumorer
DK1282616T3 (da)	2004-09-20	Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
DK1150991T3 (da)	2004-06-07	Præparater til behandling af inflammatoriske reaktioner
DK1392318T3 (da)	2007-06-25	15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse
DK1380121T3 (da)	2007-12-27	Fremgangsmåde til fremstilling af oxazolidinoner
DK1324970T3 (da)	2009-01-05	Retinoider til behandling af emfysem
DK1176964T3 (da)	2007-01-15	Brug af ET743 til behandling af cancer
DK2189162T3 (da)	2014-02-03	Fremgangsmåder til behandling af cellulære proliferative forstyrrelser
DK1206436T3 (da)	2005-02-14	Retinoider til behandling af emfysem
DK1350521T3 (da)	2008-11-10	Immunoterapeutiske kombinationer til behandling af tumorer
DK1292586T3 (da)	2004-08-30	Fremgangsmåde til fremstilling af pyrazolopyrimidinoner
DK1268482T3 (da)	2003-12-22	Pyranoindoler til behandling af glaukom